Johnson & Johnson in talks to buy $10bn neuroscience drugmaker Intra-Cellular
- Posted on January 13, 2025
- By Financial Times
- 4 Views
Johnson & Johnson in talks to buy $10bn neuroscience drugmaker Intra-Cellular
Deal would represent revival in activity after a slow year for biotech M&A
